✦ LIBER ✦

Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial

✍ Scribed by B. I. ERIKSSON; O. E. DAHL; N. ROSENCHER; A. A. KURTH; C. N. VAN DIJK; S. P. FROSTICK; P. KÄLEBO; A. V. CHRISTIANSEN; S. HANTEL; R. HETTIARACHCHI; J. SCHNEE; H. R. BÜLLER; FOR THE RE-MODEL STUDY GROUP

Book ID: 109152312
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 173 KB
Volume: 5
Category: Article
ISSN: 1538-7933
DOI: 10.1111/j.1538-7836.2007.02748.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral Thrombin Inhibitor Dabigatran Etexi

Oral Thrombin Inhibitor Dabigatran Etexilate vs North American Enoxaparin Regimen for Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 301 KB

A new oral direct thrombin inhibitor, da

A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial

✍ B. I. ERIKSSON; O. E. DAHL; H. R. BÜLLER; R. HETTIARACHCHI; N. ROSENCHER; M-L. B 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

Rivaroxaban-an oral, direct Factor Xa in

Rivaroxaban-an oral, direct Factor Xa inhibitor-for the prevention of venous thromboembolism after total knee replacement: Results of a randomized multi-center trial

✍ Jay R. Lieberman; Nadia Rosencher; Frank Misselwitz 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 20 KB

The direct thrombin inhibitor melagatran

The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study

✍ B. I. Eriksson; G. Agnelli; A. T. Cohen; O. E. Dahl; M. R. Lassen; P. Mouret; N. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

Single intravenous administration of TB-

Single intravenous administration of TB-402 for the prophylaxis of venous thromboembolism after total knee replacement: a dose-escalating, randomized, controlled trial

✍ P. VERHAMME; M. TANGELDER; R. VERHAEGHE; W. AGENO; S. GLAZER; M. PRINS; M. JACQU 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 260 KB

BAY 59-7939: an oral, direct Factor Xa i

BAY 59-7939: an oral, direct Factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study

✍ A. G. G. TURPIE; W. D. FISHER; K. A. BAUER; L. M. KWONG; M. W. IRWIN; P. KÄLEBO; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB